INFLARX N.V. reports a Return on Equity (ROE) of -116.20%.

What is IFRX's dividend yield?

INFLARX N.V. offers a dividend yield of 0.00%.

What is IFRX's Deepscope Quality Score?

Deepscope rates IFRX's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy IFRX?

Deepscope's AI Timing Score for IFRX is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does IFRX belong to?

INFLARX N.V. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu IFRX (NASDAQ) | INFLARX N.V.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-04 | FS: 2026-03-31)

IFRX

INFLARX N.V.

US:NASDAQ STOCK Healthcare >> Biotechnology News 90

USD 2.00

-0.06 (-2.91%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-116.2%

ROE

-87.7%

ROA

0.00%

Div Yield

INFLARX N.V.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.00 Price -0.06 (-2.91%) Day Change	NEWS SCORE: 90

IFRX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 15) và Thời điểm mua ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	90
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.00
PBV / Sector	8.00 / 4.58
Earning Per Share	-0.29

PE / Sector	N/A / 17.10
PEG or PE/Growth / Sector	N/A / 0.52
Average 1M Daily Value	5.55 M GREAT
Average 1W Daily Value	2.41 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-146,303.92 / 450.23
NPM Average (%) / Sector	-99,325.41 / -1,506.33
NPM Change Average (%) / Sector	N/A / 4,941.30
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-87.68 / 30.58
ROA Average (%) / Sector	-59.05 / -347.17
ROA Change Average (%) / Sector	34.12 / 5,125.52 GREAT
ROE (%) / Sector	-116.20 / -3.58
ROE Average (%) / Sector	-75.21 / 40.65
ROE Change Average (%) / Sector	39.30 / 2,109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.50
Dividend Change Average (%) / Sector	N/A / 5.02

Chi tiết đăng ký

Analyze Date	2026-06-05 09:12:26
Symbol	IFRX
Name	INFLARX N.V.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	147.29 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	295.32 / 8,655.90

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Winzerlaer Str. 2, Jena, Germany, 07745

Phone: 49 3641 508 180

Website: https://www.inflarx.de

Employees: 65

Sector: Healthcare >> Biotechnology

Description: InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a a first-in-class monoclonal anti-human complement factor C5a antibody, which is in Phase 3 clinical trial for the treatment for patients suffering from early septic organ dysfunction, biological proof of concept was established, demonstrating its unique C5a blocking ability and selectivity; Izicopan, an oral, low molecular weight drug to target C5aR with high affinity and selectivity has completed completing Phase 2a trials; and IFX002, an advancement of vilobelimab technology, which is in preclinical development for the treatment of chronic inflammatory indications. It has co-development agreement with Staidson (Beijing) BioPharmaceuticals Co., Ltd.; Cell line sales agreement with Catalent Pharma Solutions LLC; Clinical Trial Collaboration Agreement with the U.S. DHHSs, Administration for Strategic Preparedness and Response (ASPR), BARDA and PPD Development, L.P., or PPD. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.